GMRE Quote, Financials, Valuation and Earnings

Bluerock Homes Trust has a net margin of 10.29% compared to Global Medical REIT's net margin of 0.02%. Global Medical REIT's return on equity of 1.4% beat Bluerock Homes Trust's return on equity of 0.15%.

Global Medical REIT has a consensus price target of $9.09, signalling upside risk potential of 27.19%. On the other hand Bluerock Homes Trust has an analysts' consensus of $15.00 which suggests that it could grow by 4.09%. Given that Global Medical REIT has higher upside potential than Bluerock Homes Trust, analysts believe Global Medical REIT is more attractive than Bluerock Homes Trust.

Global Medical REIT has a beta of 1.158, which suggesting that the stock is 15.774% more volatile than S&P 500. In comparison Bluerock Homes Trust has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Global Medical REIT has a quarterly dividend of $0.15 per share corresponding to a yield of 9.37%. Bluerock Homes Trust offers a yield of 1.74% to investors and pays a quarterly dividend of $0.13 per share. Global Medical REIT pays 990.35% of its earnings as a dividend. Bluerock Homes Trust pays out 22925% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Global Medical REIT quarterly revenues are $34.6M, which are larger than Bluerock Homes Trust quarterly revenues of $16.4M. Global Medical REIT's net income of $3.6M is higher than Bluerock Homes Trust's net income of $4K. Notably, Global Medical REIT's price-to-earnings ratio is 238.33x while Bluerock Homes Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global Medical REIT is 3.43x versus 1.00x for Bluerock Homes Trust. Usually stocks with elevated PS ratios are considered overvalued.

Lineage has a net margin of 10.29% compared to Global Medical REIT's net margin of --. Global Medical REIT's return on equity of 1.4% beat Lineage's return on equity of -6.96%.

Global Medical REIT has a consensus price target of $9.09, signalling upside risk potential of 27.19%. On the other hand Lineage has an analysts' consensus of $54.67 which suggests that it could grow by 33.82%. Given that Lineage has higher upside potential than Global Medical REIT, analysts believe Lineage is more attractive than Global Medical REIT.

Global Medical REIT has a beta of 1.158, which suggesting that the stock is 15.774% more volatile than S&P 500. In comparison Lineage has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Global Medical REIT has a quarterly dividend of $0.15 per share corresponding to a yield of 9.37%. Lineage offers a yield of 0% to investors and pays a quarterly dividend of $0.53 per share. Global Medical REIT pays 990.35% of its earnings as a dividend. Lineage pays out -35.24% of its earnings as a dividend.

Global Medical REIT quarterly revenues are $34.6M, which are smaller than Lineage quarterly revenues of $1.3B. Global Medical REIT's net income of $3.6M is higher than Lineage's net income of --. Notably, Global Medical REIT's price-to-earnings ratio is 238.33x while Lineage's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global Medical REIT is 3.43x versus 1.71x for Lineage. Usually stocks with elevated PS ratios are considered overvalued.

Seven Hills Realty Trust has a net margin of 10.29% compared to Global Medical REIT's net margin of 69.76%. Global Medical REIT's return on equity of 1.4% beat Seven Hills Realty Trust's return on equity of 6.27%.

Global Medical REIT has a consensus price target of $9.09, signalling upside risk potential of 27.19%. On the other hand Seven Hills Realty Trust has an analysts' consensus of $14.50 which suggests that it could grow by 29.23%. Given that Seven Hills Realty Trust has higher upside potential than Global Medical REIT, analysts believe Seven Hills Realty Trust is more attractive than Global Medical REIT.

Global Medical REIT has a beta of 1.158, which suggesting that the stock is 15.774% more volatile than S&P 500. In comparison Seven Hills Realty Trust has a beta of 0.652, suggesting its less volatile than the S&P 500 by 34.79%.

Global Medical REIT has a quarterly dividend of $0.15 per share corresponding to a yield of 9.37%. Seven Hills Realty Trust offers a yield of 12.48% to investors and pays a quarterly dividend of $0.35 per share. Global Medical REIT pays 990.35% of its earnings as a dividend. Seven Hills Realty Trust pays out 117.78% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Global Medical REIT quarterly revenues are $34.6M, which are larger than Seven Hills Realty Trust quarterly revenues of $6.5M. Global Medical REIT's net income of $3.6M is lower than Seven Hills Realty Trust's net income of $4.5M. Notably, Global Medical REIT's price-to-earnings ratio is 238.33x while Seven Hills Realty Trust's PE ratio is 9.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global Medical REIT is 3.43x versus 5.85x for Seven Hills Realty Trust. Usually stocks with elevated PS ratios are considered overvalued.

Strawberry Fields REIT has a net margin of 10.29% compared to Global Medical REIT's net margin of 4.24%. Global Medical REIT's return on equity of 1.4% beat Strawberry Fields REIT's return on equity of 7.59%.

Global Medical REIT has a consensus price target of $9.09, signalling upside risk potential of 27.19%. On the other hand Strawberry Fields REIT has an analysts' consensus of $12.86 which suggests that it could grow by 26.56%. Given that Global Medical REIT has higher upside potential than Strawberry Fields REIT, analysts believe Global Medical REIT is more attractive than Strawberry Fields REIT.

Global Medical REIT has a beta of 1.158, which suggesting that the stock is 15.774% more volatile than S&P 500. In comparison Strawberry Fields REIT has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Global Medical REIT has a quarterly dividend of $0.15 per share corresponding to a yield of 9.37%. Strawberry Fields REIT offers a yield of 5.41% to investors and pays a quarterly dividend of $0.14 per share. Global Medical REIT pays 990.35% of its earnings as a dividend. Strawberry Fields REIT pays out 98.54% of its earnings as a dividend. Strawberry Fields REIT's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Global Medical REIT's is not.

Global Medical REIT quarterly revenues are $34.6M, which are smaller than Strawberry Fields REIT quarterly revenues of $37.3M. Global Medical REIT's net income of $3.6M is higher than Strawberry Fields REIT's net income of $1.6M. Notably, Global Medical REIT's price-to-earnings ratio is 238.33x while Strawberry Fields REIT's PE ratio is 17.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global Medical REIT is 3.43x versus 0.69x for Strawberry Fields REIT. Usually stocks with elevated PS ratios are considered overvalued.